Liquidity & Technicals
Liquidity & Technicals
A 5% portfolio position in ELV is implementable for funds up to roughly $11.4B at a 20% participation rate over five trading days; the stock trades $514M per day, so liquidity is not the binding constraint. The tape is mid-cycle: a one-month +21% rebound has lifted price 9.8% above the 200-day SMA, but the 50-day moved below the 200-day on March 20, and 8 of the 10 highest-volume days in a decade have been down days — the rally is real, but the structural downtrend has not yet broken.
1. Portfolio implementation verdict
5-Day Capacity (20% ADV, $M)
Largest 5-Day Position (% mkt cap)
Supported Fund AUM @ 5% ($M, 20% ADV)
ADV 20d / Mkt Cap (%)
Technical Stance Score (-3 to +3)
2. Price snapshot
Current Price ($)
YTD Return
1-Year Return
52-Week Position (0=low, 100=high)
Realized Vol 30d (%)
The 52-week percentile sits at 53.7 — neither stretched nor washed-out — but masks a violent round-trip: the stock printed an all-time high at $562.29 in September 2024 and a 52-week low of $274.31 in mid-2025 before the recent recovery. Beta is not available in the staged data; realized volatility of 27.8% (above the 10-year median of 24.9%) substitutes as a risk gauge.
3. Ten-year price action: regime broken in late 2024
Price is currently $356.13, sitting 9.8% above the 200-day SMA ($324.28) but with the 50-day SMA still below the 200-day. The chart shows three regimes: a $130-to-$560 secular uptrend from 2016 through September 2024, a 50% drawdown to $273 by mid-2025, and a six-month chop in the $300-to-$430 band. Today's tape is a counter-trend rally inside that range, not a confirmed reversal — the 50/200 cross would need to flip back before the regime label changes from broken to repaired.
4. Relative strength vs benchmark + sector
5. Momentum: RSI and MACD
Near-term momentum is the most bullish input. RSI(14) closed at 75.7 — overbought territory and the highest reading since the 2024 peak. The MACD histogram has expanded to +4.7, with the line ($10.79) well above signal ($6.06). Both confirm strong upside thrust over the last month. The risk: RSI prints above 75 are typically followed by mean-reversion within two to four weeks unless a fundamental catalyst sustains them, and there is no Q1 print yet from the company.
6. Volume, volatility, and sponsorship
Sponsorship has been net-distributive. Eight of the ten heaviest-volume sessions of the past decade are down days, including all three of the largest spikes shown above — each tied to an earnings disappointment. The recent +21% one-month rally has not been accompanied by an equivalent volume signature; conviction is asymmetric. Realized volatility at 27.8% sits between the 10-year median (24.9%) and the 80th-percentile band (32.0%), placing the name in the elevated-but-not-stressed zone. Wider stops are warranted.
7. Institutional liquidity panel
ADV 20d (k shares)
ADV 20d Value ($M)
ADV 60d (k shares)
ADV / Mkt Cap (%)
Annual Turnover (%)
ELV trades $514M per day on 1.6M shares, equivalent to 0.64% of float per session and an annualized turnover of 216% — well into deep-institutional territory.
Fund-capacity scenarios
Liquidation runway by issuer-level position size
Median 60-day daily range is 1.29% — tight by large-cap standards, implying limited intraday impact cost on standard institutional clip sizes. A 0.5% issuer-level position ($400M) clears in four days at 20% ADV and eight days at 10% ADV; a 1% position needs eight to fifteen days; anything beyond 1% becomes a multi-week unwind. For most multi-strategy and long-only funds, a 5% portfolio weight is implementable up to roughly $11B in AUM at 20% ADV without forcing a meaningful concession.
8. Technical scorecard and stance
Stance: neutral with bearish structural bias on a 3-to-6 month horizon. The one-month rebound is genuine momentum, not a quiet drift, but every prior leg up since the September 2024 peak has failed inside the $385–$430 band. The tape needs to do two things to convert from rally to reversal: reclaim and hold $385 (the most recent supply zone, where the failed January golden cross began) and force the 50-day SMA back above the 200-day. Below $324 (the 200-day SMA), the death-cross thesis re-asserts and the natural next test is the $274 52-week low.
Bullish confirmation: $385. Bearish confirmation: $324.
Liquidity is not the constraint. A patient builder with a 6-to-12-month horizon can stage in size; the right action for an opportunistic risk-on fund is to wait for a higher-quality entry (either a pullback to the $325–$330 zone with RSI at 50, or a clean break above $385 on volume) rather than buy an RSI-75 print. Avoid chasing.